SEC Filing Summary: Athira Pharma, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Athira Pharma, Inc. on May 12, 2022. The filing serves to report the Company's financial results for the quarter ended March 31, 2022, as detailed in a press release furnished as Exhibit 99.1. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in Bothell, WA.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release (Exhibit 99.1) but are not explicitly stated in the body of this 8-K document.
Material Changes
The filing does not provide specific data points to compare against the prior comparable period. It solely announces the issuance of the Q1 2022 financial results.
Guidance, Outlook, and Risks
Management Commentary and Disclosure Channels: The Company utilizes various channels for material disclosures, including SEC filings, press releases, public conference calls, its website (www.athira.com), and social media platforms (Twitter, LinkedIn, Facebook). Investors are encouraged to monitor these channels for updates on product candidates and other material matters.
Legal Disclaimer: The information furnished under Items 2.02 and 7.01, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated May 12, 2022) for specific Q1 2022 financial figures (revenue, net loss, cash position).
- Verify the Company's status as an Emerging Growth Company and its election regarding extended transition periods for accounting standards.
- Monitor the Company's official investor relations website and social media accounts for further updates on product candidates.
- Confirm the trading symbol ATHA on The Nasdaq Global Select Market.